Tarsus Pharmaceuticals
Price & Volume
Stats
See moreOpen | $50.07 |
Previous Close | $49.97 |
Day Range | $48.75-$50.07 |
52W Range | $20.08-$57.28 |
Market Cap | $2B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $182.9M |
Revenue Growth (YoY) | 407.9% |
Gross Profit (12 Mos) | $116.7M |
Diluted EPS | -$3.07 |
News
See moreYahoo Finance • 12 days ago
Tarsus Announces Pricing of Upsized $125.0 Million Public Offering
Yahoo Finance • 12 days ago
Tarsus Announces Proposed $100.0 Million Public Offering
Yahoo Finance • 18 days ago
Tarsus to Participate in Upcoming Investor Conference
Yahoo Finance • last month
Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025
About
CEO | Dr. Bobak R. Azamian M.D. |
CFO | Mr. Jeffrey S. Farrow CPA |
Address | 15440 Laguna Canyon Road, Irvine, CA, United States, 92618 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 323 |
